Frost & Sullivan's Advanced Medical Technologies Research Tracks Opportunities in Markets Influenced by Dynamic Car... (livery 2010 to 2012 compendium profiles...)

HOME >> MEDICINE >> TECHNOLOGY

Frost & Sullivan's Advanced Medical Technologies Research Tracks Opportunities in Markets Influenced by Dynamic Care Pathways

Date:3/21/2012

livery, 2010 to 2012 compendium profiles research within the global Advanced Medical Technologies Growth Partnership Services program, which also includes the following research: Compression Therapy Devices Market in Western Europe, Analysis of the U.S. Multiparameter Patient Monitoring Equipment Market, Analysis of the Orthopedic Implants Market—The Future of Joint Replacements, Custom Procedure Trays and Packs Move Toward Standardization, and Operating Rooms of the Future: A European Perspective. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012

Contact:

Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
E: britni.myers@frost.com

http://www.frost.com

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine technology :

1. Frost & Sullivans Global Healthcare Approach Evolves to Contend with Todays Challenges
2. Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device
3. Frost & Sullivan Lauds Siemens Healthcares Unique, Multipurpose Gamma Camera that Sets it Apart from the Competition in the Nuclear Cardiology Market
4. A Secret to Ward Off Jack Frosts Drying Effect on Your Skin: The AmLactin® Family of Moisturizers
5. Frost and Sullivan Recognizes AT&Ts Innovative mHealth Strategy
6. Frost & Sullivan Honors Acuo Technologies with Product Leadership Award in Medical Imaging Informatics
7. KJAYA Medical Honored with 2011 Frost & Sullivan Award for Technology Innovation in Web-based Medical Imaging Data Management
8. Frost & Sullivan Speaks Candidly with U.S. Pharmacists
9. Frost & Sullivan Honors ZONARE for Ultrasound Innovation
10. Awarepoint Corporation Receives Frost & Sullivans 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award
11. China Medicine Corporation Dismisses Frazer Frost as Auditor

Post Your Comments:

(Date:5/23/2013)... , May 24, 2013 3SBio ... the "Company"), a leading China ... and marketing biopharmaceutical products, announced today that, at ... the Company,s shareholders voted in favor of the ... agreement and plan of merger dated February 8, ...

(Date:5/23/2013)... 2013 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... President and Chief Executive Officer of Neurocrine Biosciences, will be ... Health Care Conference in Boston. The live ... Eastern Time / 8:20 a.m. Pacific Time. The presentation will ... at http://www.neurocrine.com . If you are ...

(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...

Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 2 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3 Nephros Announces Completion of Rights Offering 2 Nephros Announces Completion of Rights Offering 3 Nephros Announces Completion of Rights Offering 4

[0] 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement [0] Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference [0] Nephros Announces Completion of Rights Offering

... AVIV, Israel, June 17 A recent clinical ... powered by 3rd,generation TriPollar(TM) technology, confirms the safety ... collagen remodeling. The peer,reviewed paper entitled "Clinical and ... Dr. Haim Kaplan,and Dr. Andrea Gat, has been ...

... Nerve Growth Factor Has Demonstrated Promising Activity Preclinically-- , ... Huntington,s Disease and Others-- , , RESEARCH TRIANGLE ... clinical stage company developing and commercializing innovative treatments for ... that it has obtained the rights to develop and ...

Cached Medicine Technology:Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy 2 Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy 3 CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 2 CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 3

Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders

(Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...

(Date:5/24/2013)... New research suggests a link between sleep duration ... Every additional hour someone with insomnia sleeps is ... likelihood of moderate or high risk of suicide, ... "We were surprised by the strength ... risk," study author, Linden Oliver, clinical research coordinator ...

(Date:5/24/2013)... used to treat glaucoma may cause droopy eyelids and ... to a new study. The drugs, known as ... pressure, have already been shown to cause blurred vision, ... suggesting that the new findings could lead to labeling ... when prescribing these drugs, the researchers added, particularly as ...

(Date:5/24/2013)... CA (PRWEB) May 24, 2013 Area homeowners ... selection of new hot tubs to choose from at factory-direct ... Sale . The sales event takes place at Emerald ... 26, 2013. , Jacuzzi, the industry's leading hot tub ... traveling across the country. The event will feature popular hot ...

(Date:5/24/2013)... mutations central to the development of infantile myofibromatosis (IM)a ... and soft tissuemay provide new therapeutic targets, according to ... Sinai. The findings, published in the American Journal ... options for this debilitating disease, for which the only ... tumors. , IM is an inheritied disorder that develops ...

Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2 Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2 Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2 Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2 Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2

[0] Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team [0] Sleep Duration Linked to Suicidal Thoughts in People With Insomnia [0] Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds [0] Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event [0] Researchers identify first drug targets in childhood genetic tumor disorder

... Del., Nov. 2 Staff and board,members of Delaware ... Lloyd, MSN, RN, for 20 years of service at ... has guided Delaware Hospice from a fledgling,grassroots organization to ... community support with quality and compassion., In 1987, ...

... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed ... challenge of the patents listed by,Novartis Pharmaceuticals Corporation ... capsules, 10mg, 20mg, 30mg,and 40mg. Barr filed ... IV certification for a generic Ritalin LA product ...

... SOUTH PORTLAND, Maine, Nov. 2 Small employers ... much larger businesses. Anthem,Blue Cross and Blue Shield ... for small businesses (50 or fewer employees) under ... health insurance,choices than have ever been available for ...

... Urology; Initiated for ... Dermatology and OB/GYN, ... force in measuring the impact of pharmaceutical promotion on,physicians, prescribing ... networks in alignment with emerging market,trends and rising client demand. ...

... Mass., Nov. 2 Pressure,BioSciences, Inc. (Nasdaq: PBIO ... President, and CEO, will present a corporate,overview at The ... New York City on Monday, November 5, 2007 at ... The New York Palace Hotel, New York,City. The Company,s ...

... PXS; Nasdaq: PXSL) today announced moves to expand its ... construction of a new,state of the art facility at ... the fourth quarter of 2008,Pharmaxis may lease the 7,000 ... 15 years with two options to renew of five ...

Cached Medicine News:Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 2 Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 3 Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 2 Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 3 Health News:Anthem Introduces New Insurance Options for Small Business 2 Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 2 Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 3 Health News:Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th 2 Health News:Pharmaxis to Expand Manufacturing Capacity 2

Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN Barr Confirms Patent Challenge of Ritalin(R) LA Anthem Introduces New Insurance Options for Small Business ImpactRx Announces Expansion and Addition of Physician Information Networks Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th Pharmaxis to Expand Manufacturing Capacity

The 5524-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....

The 5539-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....

HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...

Scan internal organs percutaneously while eliminating side lobe artifact....

Medicine Products:

Multi-frequency Steered Linear Transducer Multi Frequency Linear Breast Transducer UST-5539-7.5 Multi Frequency Convex Abdominal HST Transducer with Harmonic Echo Imaging Multi Frequency Convex Abdominal Transducer with Harmonic Echo Imaging